Gene · 2272
Papers2,915
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,915
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole exome analysis reveals the genomic profiling related to chemo-resistance in Chinese population with limited-disease small cell lung cancer. | Cancer Med | 2023 | 35735600 | PubTator, text mining | PubMed |
| Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder. | World J Biol Psychiatry | 2023 | 35615967 | PubTator, text mining | PubMed |
| Genome-wide DNA methylome and transcriptome changes induced by inorganic nanoparticles in human kidney cells after chronic exposure. | Cell Biol Toxicol | 2023 | 34973136 | PubTator, text mining | PubMed |
| A multi-platform reference for somatic structural variation detection. | Cell Genom | 2022 | 36778136 | PubTator, text mining | PubMed |
| Candidate targets of copy number deletion events across 17 cancer types. | Front Genet | 2022 | 36726722 | PubTator, text mining | PubMed |
| Editorial: Chromosomal fragile sites, genome instability and human diseases. | Front Genet | 2022 | 36704360 | PubTator, text mining | PubMed |
| Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma. | Front Immunol | 2022 | 36618348 | PubTator, text mining | PubMed |
| Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer. | Cancers (Basel) | 2022 | 36612264 | PubTator, text mining | PubMed |
| Research Progress on the Predicting Factors and Coping Strategies for Postoperative Recurrence of Esophageal Cancer. | Cells | 2022 | 36611908 | PubTator, text mining | PubMed |
| Single-cell resolved ploidy and chromosomal aberrations in nonalcoholic steatohepatitis-(NASH) induced hepatocellular carcinoma and its precursor lesions. | Sci Rep | 2022 | 36587184 | PubTator, text mining | PubMed |
| Downregulation of the Protein C Signaling System Is Associated with COVID-19 Hypercoagulability-A Single-Cell Transcriptomics Analysis. | Viruses | 2022 | 36560757 | PubTator, text mining | PubMed |
| Pancreatic Adenosquamous Carcinoma: A Rare Pathological Subtype of Pancreatic Cancer. | J Clin Med | 2022 | 36556016 | PubTator, text mining | PubMed |
| Recent advances in esophageal squamous cell precancerous conditions: A review. | Medicine (Baltimore) | 2022 | 36550838 | PubTator, text mining | PubMed |
| Sialyltransferases and Neuraminidases: Potential Targets for Cancer Treatment. | Diseases | 2022 | 36547200 | PubTator, text mining | PubMed |
| Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer. | Front Immunol | 2022 | 36544755 | PubTator, text mining | PubMed |
| FANCD2 promotes mitotic rescue from transcription-mediated replication stress in SETX-deficient cancer cells. | Commun Biol | 2022 | 36543851 | PubTator, text mining | PubMed |
| Detection of somatic copy number deletion of the CDKN2A gene by quantitative multiplex PCR for clinical practice. | Front Oncol | 2022 | 36531022 | PubTator, text mining | PubMed |
| Epigenomic signatures associated with spontaneous and replication stress-induced DNA double strand breaks. | Front Genet | 2022 | 36506300 | PubTator, text mining | PubMed |
| Fragile sites, chromosomal lesions, tandem repeats, and disease. | Front Genet | 2022 | 36468036 | PubTator, text mining | PubMed |
| Genetics, epigenetics and transgenerational transmission of obesity in children. | Front Endocrinol (Lausanne) | 2022 | 36452324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2272/papers?page=11